Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
World
Adam Eckert

UNBELIEVABLE: Why novavax stock is up 11 today | History Defined

Novavax Inc (NASDAQ:NVAX) shares are trading higher Thursday after the company announced that its COVID-19 vaccine was recommended for an expanded conditional marketing authorization in the European Union for adolescents aged 12 through 17.

The European Medicines Agency committee based its recommendation of Nuvaxovid on results from the Phase 3 PREVENT-19 clinical trial. Nuvaxoid is a protein-based vaccine engineered from the genetic sequence of the first strain of SARS-CoV-2, the virus that causes COVID-19 disease. 

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.